Chapter/Section Purchase

1 Study Coverage
1.1 Vector-Based RNAi Product Introduction
1.2 Market by Type
1.2.1 Global Vector-Based RNAi Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 siRNA Design
1.2.3 siRNA Vectors
1.2.4 Custom siRNA Construction
1.3 Market by Application
1.3.1 Global Vector-Based RNAi Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospitals
1.3.3 Speciality Clinics
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Vector-Based RNAi Sales Estimates and Forecasts 2017-2028
2.2 Global Vector-Based RNAi Revenue Estimates and Forecasts 2017-2028
2.3 Global Vector-Based RNAi Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Vector-Based RNAi Sales by Region
2.4.1 Global Vector-Based RNAi Sales by Region (2017-2022)
2.4.2 Global Sales Vector-Based RNAi by Region (2023-2028)
2.5 Global Vector-Based RNAi Revenue by Region
2.5.1 Global Vector-Based RNAi Revenue by Region (2017-2022)
2.5.2 Global Vector-Based RNAi Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Vector-Based RNAi Sales by Manufacturers
3.1.1 Global Top Vector-Based RNAi Manufacturers by Sales (2017-2022)
3.1.2 Global Vector-Based RNAi Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Vector-Based RNAi in 2021
3.2 Global Vector-Based RNAi Revenue by Manufacturers
3.2.1 Global Vector-Based RNAi Revenue by Manufacturers (2017-2022)
3.2.2 Global Vector-Based RNAi Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Vector-Based RNAi Revenue in 2021
3.3 Global Vector-Based RNAi Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Vector-Based RNAi Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Vector-Based RNAi Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Vector-Based RNAi Sales by Type
4.1.1 Global Vector-Based RNAi Historical Sales by Type (2017-2022)
4.1.2 Global Vector-Based RNAi Forecasted Sales by Type (2023-2028)
4.1.3 Global Vector-Based RNAi Sales Market Share by Type (2017-2028)
4.2 Global Vector-Based RNAi Revenue by Type
4.2.1 Global Vector-Based RNAi Historical Revenue by Type (2017-2022)
4.2.2 Global Vector-Based RNAi Forecasted Revenue by Type (2023-2028)
4.2.3 Global Vector-Based RNAi Revenue Market Share by Type (2017-2028)
4.3 Global Vector-Based RNAi Price by Type
4.3.1 Global Vector-Based RNAi Price by Type (2017-2022)
4.3.2 Global Vector-Based RNAi Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Vector-Based RNAi Sales by Application
5.1.1 Global Vector-Based RNAi Historical Sales by Application (2017-2022)
5.1.2 Global Vector-Based RNAi Forecasted Sales by Application (2023-2028)
5.1.3 Global Vector-Based RNAi Sales Market Share by Application (2017-2028)
5.2 Global Vector-Based RNAi Revenue by Application
5.2.1 Global Vector-Based RNAi Historical Revenue by Application (2017-2022)
5.2.2 Global Vector-Based RNAi Forecasted Revenue by Application (2023-2028)
5.2.3 Global Vector-Based RNAi Revenue Market Share by Application (2017-2028)
5.3 Global Vector-Based RNAi Price by Application
5.3.1 Global Vector-Based RNAi Price by Application (2017-2022)
5.3.2 Global Vector-Based RNAi Price Forecast by Application (2023-2028)
6 North America
6.1 North America Vector-Based RNAi Market Size by Type
6.1.1 North America Vector-Based RNAi Sales by Type (2017-2028)
6.1.2 North America Vector-Based RNAi Revenue by Type (2017-2028)
6.2 North America Vector-Based RNAi Market Size by Application
6.2.1 North America Vector-Based RNAi Sales by Application (2017-2028)
6.2.2 North America Vector-Based RNAi Revenue by Application (2017-2028)
6.3 North America Vector-Based RNAi Market Size by Country
6.3.1 North America Vector-Based RNAi Sales by Country (2017-2028)
6.3.2 North America Vector-Based RNAi Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Vector-Based RNAi Market Size by Type
7.1.1 Europe Vector-Based RNAi Sales by Type (2017-2028)
7.1.2 Europe Vector-Based RNAi Revenue by Type (2017-2028)
7.2 Europe Vector-Based RNAi Market Size by Application
7.2.1 Europe Vector-Based RNAi Sales by Application (2017-2028)
7.2.2 Europe Vector-Based RNAi Revenue by Application (2017-2028)
7.3 Europe Vector-Based RNAi Market Size by Country
7.3.1 Europe Vector-Based RNAi Sales by Country (2017-2028)
7.3.2 Europe Vector-Based RNAi Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Vector-Based RNAi Market Size by Type
8.1.1 Asia Pacific Vector-Based RNAi Sales by Type (2017-2028)
8.1.2 Asia Pacific Vector-Based RNAi Revenue by Type (2017-2028)
8.2 Asia Pacific Vector-Based RNAi Market Size by Application
8.2.1 Asia Pacific Vector-Based RNAi Sales by Application (2017-2028)
8.2.2 Asia Pacific Vector-Based RNAi Revenue by Application (2017-2028)
8.3 Asia Pacific Vector-Based RNAi Market Size by Region
8.3.1 Asia Pacific Vector-Based RNAi Sales by Region (2017-2028)
8.3.2 Asia Pacific Vector-Based RNAi Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Vector-Based RNAi Market Size by Type
9.1.1 Latin America Vector-Based RNAi Sales by Type (2017-2028)
9.1.2 Latin America Vector-Based RNAi Revenue by Type (2017-2028)
9.2 Latin America Vector-Based RNAi Market Size by Application
9.2.1 Latin America Vector-Based RNAi Sales by Application (2017-2028)
9.2.2 Latin America Vector-Based RNAi Revenue by Application (2017-2028)
9.3 Latin America Vector-Based RNAi Market Size by Country
9.3.1 Latin America Vector-Based RNAi Sales by Country (2017-2028)
9.3.2 Latin America Vector-Based RNAi Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Vector-Based RNAi Market Size by Type
10.1.1 Middle East and Africa Vector-Based RNAi Sales by Type (2017-2028)
10.1.2 Middle East and Africa Vector-Based RNAi Revenue by Type (2017-2028)
10.2 Middle East and Africa Vector-Based RNAi Market Size by Application
10.2.1 Middle East and Africa Vector-Based RNAi Sales by Application (2017-2028)
10.2.2 Middle East and Africa Vector-Based RNAi Revenue by Application (2017-2028)
10.3 Middle East and Africa Vector-Based RNAi Market Size by Country
10.3.1 Middle East and Africa Vector-Based RNAi Sales by Country (2017-2028)
10.3.2 Middle East and Africa Vector-Based RNAi Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Merck & Co.
11.1.1 Merck & Co. Corporation Information
11.1.2 Merck & Co. Overview
11.1.3 Merck & Co. Vector-Based RNAi Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Merck & Co. Vector-Based RNAi Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Merck & Co. Recent Developments
11.2 Phio Pharmaceutical
11.2.1 Phio Pharmaceutical Corporation Information
11.2.2 Phio Pharmaceutical Overview
11.2.3 Phio Pharmaceutical Vector-Based RNAi Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Phio Pharmaceutical Vector-Based RNAi Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Phio Pharmaceutical Recent Developments
11.3 Quark Pharmaceuticals
11.3.1 Quark Pharmaceuticals Corporation Information
11.3.2 Quark Pharmaceuticals Overview
11.3.3 Quark Pharmaceuticals Vector-Based RNAi Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Quark Pharmaceuticals Vector-Based RNAi Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Quark Pharmaceuticals Recent Developments
11.4 Thermo Fisher Scientific
11.4.1 Thermo Fisher Scientific Corporation Information
11.4.2 Thermo Fisher Scientific Overview
11.4.3 Thermo Fisher Scientific Vector-Based RNAi Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Thermo Fisher Scientific Vector-Based RNAi Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Thermo Fisher Scientific Recent Developments
11.5 Silence Therapeutics
11.5.1 Silence Therapeutics Corporation Information
11.5.2 Silence Therapeutics Overview
11.5.3 Silence Therapeutics Vector-Based RNAi Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Silence Therapeutics Vector-Based RNAi Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Silence Therapeutics Recent Developments
11.6 Qiagen NV
11.6.1 Qiagen NV Corporation Information
11.6.2 Qiagen NV Overview
11.6.3 Qiagen NV Vector-Based RNAi Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Qiagen NV Vector-Based RNAi Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Qiagen NV Recent Developments
11.7 Ionis Pharmaceutical
11.7.1 Ionis Pharmaceutical Corporation Information
11.7.2 Ionis Pharmaceutical Overview
11.7.3 Ionis Pharmaceutical Vector-Based RNAi Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Ionis Pharmaceutical Vector-Based RNAi Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Ionis Pharmaceutical Recent Developments
11.8 Dicerna Pharmaceuticals
11.8.1 Dicerna Pharmaceuticals Corporation Information
11.8.2 Dicerna Pharmaceuticals Overview
11.8.3 Dicerna Pharmaceuticals Vector-Based RNAi Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Dicerna Pharmaceuticals Vector-Based RNAi Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Dicerna Pharmaceuticals Recent Developments
11.9 Arrowhead Pharmaceuticals
11.9.1 Arrowhead Pharmaceuticals Corporation Information
11.9.2 Arrowhead Pharmaceuticals Overview
11.9.3 Arrowhead Pharmaceuticals Vector-Based RNAi Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Arrowhead Pharmaceuticals Vector-Based RNAi Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Arrowhead Pharmaceuticals Recent Developments
11.10 Arcturus Therapeutics
11.10.1 Arcturus Therapeutics Corporation Information
11.10.2 Arcturus Therapeutics Overview
11.10.3 Arcturus Therapeutics Vector-Based RNAi Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Arcturus Therapeutics Vector-Based RNAi Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Arcturus Therapeutics Recent Developments
11.11 Alnylam Pharmaceuticals
11.11.1 Alnylam Pharmaceuticals Corporation Information
11.11.2 Alnylam Pharmaceuticals Overview
11.11.3 Alnylam Pharmaceuticals Vector-Based RNAi Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Alnylam Pharmaceuticals Vector-Based RNAi Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Alnylam Pharmaceuticals Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Vector-Based RNAi Industry Chain Analysis
12.2 Vector-Based RNAi Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Vector-Based RNAi Production Mode & Process
12.4 Vector-Based RNAi Sales and Marketing
12.4.1 Vector-Based RNAi Sales Channels
12.4.2 Vector-Based RNAi Distributors
12.5 Vector-Based RNAi Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Vector-Based RNAi Industry Trends
13.2 Vector-Based RNAi Market Drivers
13.3 Vector-Based RNAi Market Challenges
13.4 Vector-Based RNAi Market Restraints
14 Key Findings in The Global Vector-Based RNAi Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer